With a background in biotechnology Lisa Mead counsels clients on strategic intellectual property (IP) issues in biotechnology, pharmaceutical chemistry, formulations, biologics, drug-device combination products, and medical devices. Lisa provides counseling on patent prosecution and trade secret issues to both domestic and international clients, and is skilled in all aspects of patent prosecution and procurement. She has experience conducting intellectual property due diligence, conducting freedom to operate analyses, and performing infringement analyses in various technologies.
In addition to providing patent counseling, Lisa handles intellectual property aspects of various types of transactions, including license agreements and consulting agreements relating to drug-device combination products and life sciences technologies.
Before joining Morgan Lewis, Lisa worked at Teva Pharmaceuticals as patent counsel, handling patent portfolios and intellectual property matters for respiratory products, including drug-device combination products for small molecule and biologic formulations. Prior to Teva, she was an associate at a Philadelphia-area IP boutique law firm, where she served as a scientific advisor and a patent agent prior to graduating law school.
Before starting law school, Lisa worked as a scientist in the Clinical Pharmacology department of Johnson & Johnson, and at the American Red Cross, where she performed DNA sequencing for bone marrow transplant patients and their potential matches.
Temple University, Beasley School of Law, 2009, J.D., cum laude
Pennsylvania State University, 2001, B.S., Biotechnology